Molecular mechanisms of thyroid cancer: A competing endogenous RNA (ceRNA) point of view

Yang Liu1, Suliman Khan2, Lin Li3

  • 1Department of Thyroid Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450002, China.

Insights

Competing endogenous RNA (ceRNA) networks are crucial in thyroid cancer (TC) progression. Understanding these interactions involving long noncoding RNAs, pseudogenes, and circular RNAs offers new diagnostic and therapeutic strategies for TC.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Thyroid cancer (TC) is the most common endocrine malignancy, with complex carcinogenesis and limited treatment options.
  • Non-coding RNAs (ncRNAs) are increasingly recognized for their role in TC progression.
  • The intricate regulatory interactions among multiple ncRNAs in TC remain largely unexplored.

Purpose of the Study:

  • To review the current understanding of competing endogenous RNA (ceRNA) networks in thyroid cancer.
  • To highlight the essential roles of ceRNA networks in various hallmarks of TC.
  • To discuss the potential of ceRNA deregulation for early diagnosis and novel therapeutic targets.

Main Methods:

  • Literature review of studies investigating ncRNAs and ceRNA networks in thyroid cancer.
  • Analysis of proposed mechanisms of ceRNA interactions, including shared microRNA response elements.
  • Examination of the involvement of long noncoding RNAs, pseudogenes, and circular RNAs in ceRNA networks.

Main Results:

  • Numerous ceRNA networks are deregulated in thyroid cancer development, metastasis, migration, invasion, epithelial-mesenchymal transition (EMT), and drug resistance.
  • ceRNA mechanisms involving lncRNAs, pseudogenes, and circRNAs can modulate gene expression by influencing miRNA interactions.
  • Dysregulated ceRNA networks are implicated in critical aspects of TC progression.

Conclusions:

  • ceRNA networks play a significant role in the complex biological processes of thyroid cancer.
  • Further investigation into ceRNA deregulation can lead to improved diagnostic markers for TC.
  • Targeting ceRNA networks presents a promising avenue for developing effective therapies for thyroid cancer.

Related Concept Videos

The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.4K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.4K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
5.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
24.7K